Showing results (551-560 of 676) with videos related to

Sort By:
Pageof 68
Ecancermedicalscience|March 25, 2026
The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detectionCharles M Balch, Ning Liao, Dennis S C Lam, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 7, 2011
Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Nasim Mavaddat, Daniel Barrowdale, Irene L Andrulis, et al.
Medrxiv : the Preprint Server for Health Sciences|October 28, 2024
Genetic Variation and Regulation of MICA Alters Natural Killer Cell-Mediated Immunosurveillance in Early-Onset Colorectal CancerHeather M McGee, Joseph D Bonner, Colt Egelston, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 14, 2020
Mendelian Randomization of Circulating Polyunsaturated Fatty Acids and Colorectal Cancer RiskNikhil K Khankari, Barbara L Banbury, Maria C Borges, et al.
Journal of the National Cancer Institute|March 17, 2023
Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regionsSara Lindström, Lu Wang, Helian Feng, et al.
HGG Advances|January 20, 2022
Hemochromatosis risk genotype is not associated with colorectal cancer or age at its diagnosisGail P Jarvik, Xiaoliang Wang, Pierre Fontanillas, et al.
Nature Genetics|September 10, 2013
A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemiaSohela Shah, Kasmintan A Schrader, Esmé Waanders, et al.
Nature Genetics|October 27, 2020
Cancer therapy shapes the fitness landscape of clonal hematopoiesisKelly L Bolton, Ryan N Ptashkin, Teng Gao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2012
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriersYuan C Ding, Lesley McGuffog, Sue Healey, et al.
Pageof 68